HUMANIS

Owner

Goods & Services

Systemic anti-infectives, namely, antiparasitic, antibacterial and antifungal pharmaceuticals; Musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; Cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, and calcium antagonists being calcium channel blockers; Pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, pharmaceuticals in the nature of analgesics, psychoanaleptics, and psycoleptics for the treatment of psychosis, anti-epileptics for the treatment of epilepsy, central nervous system drugs being drugs for the treatment of central nervous system disorders, anaesthetics, antiparkinson preparations for the treatment of parkinson's disease, namely, antiparkinson pharmaceuticals; Pharmaceuticals for the treatment of respiratory diseases and asthma; Pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; Anti-diabetic pharmaceuticals; insulins; Pharmaceuticals for the treatment of Alimentary Tract and Metabolism; Pharmaceuticals for the treatment of bone diseases and joint diseases; Pharmaceuticals for the treatment of blood and blood forming organs; Pharmaceuticals for the treatment of viral and infectious diseases; Pharmaceuticals for use as antineoplastic agents, namely, pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of immune system related diseases and disorders; Pharmaceuticals for the treatment of sensory organs; Pharmaceuticals for the treatment of kidney diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for ophthalmological use